RecallDepth
Class II Terminated

Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01

Company
Sanofi-Aventis U.S. Llc
Recall Initiated
April 27, 2018
Posted
May 9, 2018
Recall Number
D-0804-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
19580 vials
Firm Location
Bridgewater, NJ, United States

Reason for Recall

Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.

Distribution

US nationwide

Lot / Code Info

Lot #: 7F307A, 7F307C, Exp 01/2019

More recalls by Sanofi-Aventis U.S. Llc

View all recalls by this company →

Other recent Class II Drug recalls